127 related articles for article (PubMed ID: 1902868)
1. Hypo-fibrinolysis in patients with hypertension and elevated cholesterol.
Jansson JH; Johansson B; Boman K; Nilsson TK
J Intern Med; 1991 Apr; 229(4):309-16. PubMed ID: 1902868
[TBL] [Abstract][Full Text] [Related]
2. Tissue plasminogen activator and plasminogen activator inhibitor-1 in stroke patients.
Lindgren A; Lindoff C; Norrving B; Astedt B; Johansson BB
Stroke; 1996 Jun; 27(6):1066-71. PubMed ID: 8650716
[TBL] [Abstract][Full Text] [Related]
3. Impaired fibrinolysis and insulin resistance in patients with hypertension.
Jeng JR; Sheu WH; Jeng CY; Huang SH; Shieh SM
Am J Hypertens; 1996 May; 9(5):484-90. PubMed ID: 8735180
[TBL] [Abstract][Full Text] [Related]
4. Impaired fibrinolysis in hypertension and obesity due to high plasminogen activator inhibitor-1 level in plasma.
Urano T; Kojima Y; Takahashi M; Serizawa K; Sakakibara K; Takada Y; Takada A
Jpn J Physiol; 1993; 43(2):221-8. PubMed ID: 8355419
[TBL] [Abstract][Full Text] [Related]
5. Lipoprotein(a), tissue plasminogen activator and plasminogen activator inhibitor 1 levels in hyperlipidaemic patients in Kuwait.
Akanji AO; Abdullah A; Tahzeeb S
Eur J Clin Invest; 1997 May; 27(5):380-6. PubMed ID: 9179544
[TBL] [Abstract][Full Text] [Related]
6. High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor.
Thögersen AM; Jansson JH; Boman K; Nilsson TK; Weinehall L; Huhtasaari F; Hallmans G
Circulation; 1998 Nov; 98(21):2241-7. PubMed ID: 9826309
[TBL] [Abstract][Full Text] [Related]
7. Inheritance conjointly contributing to fibrinolysis and hyperlipidemia.
Glueck CJ; Glueck HI; Tracy T; Speirs J; Stroop D
Metabolism; 1993 Nov; 42(11):1410-9. PubMed ID: 8231835
[TBL] [Abstract][Full Text] [Related]
8. Fibrinolytic activity in Chinese patients with diabetes or hyperlipidemia in comparison with healthy controls.
Ho CH; Jap TS
Thromb Haemost; 1991 Jan; 65(1):3-6. PubMed ID: 1902595
[TBL] [Abstract][Full Text] [Related]
9. Tissue-plasminogen activator, plasminogen activator inhibitor and risk of peripheral arterial disease.
Smith FB; Lee AJ; Rumley A; Fowkes FG; Lowe GD
Atherosclerosis; 1995 May; 115(1):35-43. PubMed ID: 7669086
[TBL] [Abstract][Full Text] [Related]
10. Interrelationships between plasma levels of plasminogen activator inhibitor, tissue plasminogen activator, lipoprotein (a), and established cardiovascular risk factors in a north Swedish population.
Sundell IB; Nilsson TK; Hallmans G; Hellsten G; Dahlén GH
Atherosclerosis; 1989 Nov; 80(1):9-16. PubMed ID: 2532510
[TBL] [Abstract][Full Text] [Related]
11. Relationship between endothelial function and fibrinolysis in early hypertension.
Tomiyama H; Kimura Y; Mitsuhashi H; Kinouchi T; Yoshida H; Kushiro T; Doba N
Hypertension; 1998 Jan; 31(1 Pt 2):321-7. PubMed ID: 9453323
[TBL] [Abstract][Full Text] [Related]
12. Hypofibrinolysis associated with vasculopathy in non insulin dependent diabetes mellitus.
García Frade LJ; de la Calle H; Torrado MC; Lara JI; Cuellar L; García Avello A
Thromb Res; 1990 Jul; 59(1):51-9. PubMed ID: 2119076
[TBL] [Abstract][Full Text] [Related]
13. Relationships between euglobulin clot lysis time and the plasma levels of tissue plasminogen activator and plasminogen activator inhibitor 1.
Urano T; Sakakibara K; Rydzewski A; Urano S; Takada Y; Takada A
Thromb Haemost; 1990 Feb; 63(1):82-6. PubMed ID: 2111051
[TBL] [Abstract][Full Text] [Related]
14. Effects of doxazosin and atenolol on the fibrinolytic system in patients with hypertension and elevated serum cholesterol.
Jansson JH; Johansson B; Boman K; Nilsson TK
Eur J Clin Pharmacol; 1991; 40(4):321-6. PubMed ID: 1828764
[TBL] [Abstract][Full Text] [Related]
15. [Decreased fibrinolytic capacity in coronary patients by increased plasminogen activator inhibitor activity].
Ihnken K; Speiser W; Müller-Berghaus G; Beyersdorf F; Schlepper M; Satter P
Helv Chir Acta; 1992 Jan; 58(4):503-8. PubMed ID: 1582860
[TBL] [Abstract][Full Text] [Related]
16. The effect of body build, diet and endocrine factors on the extrinsic fibrinolytic system in healthy young women.
Sundell IB; Nilsson TK; Hallmans G; Nygren C
Scand J Clin Lab Invest; 1988 Oct; 48(6):557-64. PubMed ID: 3146134
[TBL] [Abstract][Full Text] [Related]
17. The association of fibrinolysis and hyperlipidaemia with quantitative sensory tests in an epidemiological study of Swedish type 1 diabetic patients.
Lithner F; Bergenheim T; Borssén B; Dahlén G; Nilsson TK
Diabet Med; 1995 Jul; 12(7):590-4. PubMed ID: 7554780
[TBL] [Abstract][Full Text] [Related]
18. Hypofibrinolysis in patients with a history of idiopathic deep vein thrombosis and/or pulmonary embolism.
Grimaudo V; Bachmann F; Hauert J; Christe MA; Kruithof EK
Thromb Haemost; 1992 Apr; 67(4):397-401. PubMed ID: 1631786
[TBL] [Abstract][Full Text] [Related]
19. Components of the fibrinolytic system are differently altered in moderate and severe hypothyroidism.
Chadarevian R; Bruckert E; Leenhardt L; Giral P; Ankri A; Turpin G
J Clin Endocrinol Metab; 2001 Feb; 86(2):732-7. PubMed ID: 11158038
[TBL] [Abstract][Full Text] [Related]
20. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
Siegbahn A; Ruusuvaara L
Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
